You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › January › 01
Nordisk
6 months ago
Novo Nordisk and Eli Lilly are expected to bring GLP-1 pills to market in the new year, which is expected to boost the number being treated.
Novo Nordisk enters 2026 on the defense as it faces a ‘must-win’ battle in the U.S. market ⊕
The FDA approval of the Wegovy pill highlights many of the key themes Novo Nordisk will have to face in 2026.
page 1 of 1